Peter and Dan discuss a number of longevity and pharmaceutical companies that are working to crack the vitality code of life. Exponential technologies, from machine learning to CRISPR, are enabling scientists to probe medical data, understand aging, and reverse its processes like never before.

In this episode:

Peter discusses a startup he’s tracking that uses gene therapy to treat age and age-related diseases afflicting animals, extending pets’ healthy lifespans by nearly a decade, with no side effects.

Dan discusses a major paradigm shift in financial planning, whereby financial advisors that embrace technology are beginning to use forecasts of 120 years instead of conventional actuary tables that take by default a life expectancy of 90 years.

Peter and Dan emphasize the importance of a resilient mindset, purpose and long-term inspiration for individuals striving to maximize their longevity journeys.